Cargando…
Impact of pre-existing MSP1(42)-allele specific immunity on potency of an erythrocytic Plasmodium falciparum vaccine
BACKGROUND: MSP1 is the major surface protein on merozoites and a prime candidate for a blood stage malaria vaccine. Preclinical and seroepidemiological studies have implicated antibodies to MSP1 in protection against blood stage parasitaemia and/or reduced parasite densities, respectively. Malaria...
Autores principales: | Bergmann-Leitner, Elke S, Duncan, Elizabeth H, Mease, Ryan M, Angov, Evelina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3502560/ https://www.ncbi.nlm.nih.gov/pubmed/22958482 http://dx.doi.org/10.1186/1475-2875-11-315 |
Ejemplares similares
-
MSP-1p42-specific antibodies affect growth and development of intra-erythrocytic parasites of Plasmodium falciparum
por: Bergmann-Leitner, Elke S, et al.
Publicado: (2009) -
Immunization with Pre-Erythrocytic Antigen CelTOS from
Plasmodium falciparum Elicits Cross-Species Protection
against Heterologous Challenge with Plasmodium
berghei
por: Bergmann-Leitner, Elke S, et al.
Publicado: (2010) -
Protection Induced by Plasmodium falciparum MSP1(42) Is Strain-Specific, Antigen and Adjuvant Dependent, and Correlates with Antibody Responses
por: Lyon, Jeffrey A., et al.
Publicado: (2008) -
Comparison of Plasmodium berghei challenge models for the evaluation of pre-erythrocytic malaria vaccines and their effect on perceived vaccine efficacy
por: Leitner, Wolfgang W, et al.
Publicado: (2010) -
Plasmodium falciparum msp1, msp2 and glurp allele frequency and diversity in sub-Saharan Africa
por: Mwingira, Felista, et al.
Publicado: (2011)